Login to Your Account



Pharma: Other News To Note


Friday, October 19, 2012

• Sanofi Pasteur, of Swiftwater, Pa., the vaccines division of Sanofi SA, said it filed a supplemental biologics license application for a quadrivalent formulation of its Fluzone (influenza virus vaccine). The filing was accepted by the FDA for full review, and an action date is anticipated in the second quarter of 2013.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription